News | Magnetic Resonance Imaging (MRI) | February 14, 2019

Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement

Agreement will expand use of cardiac MRI to electrophysiology procedures through Circle’s cvi42 cardiovascular imaging platform and Galgo’s ADAS 3D EP planning software

Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement

February 14, 2019 – Circle Cardiovascular Imaging and Galgo Medical recently announced an agreement for distribution and joint development with respect to magnetic resonance imaging (MRI) scanner application products and workflows, with corresponding post-processing capabilities. The focus will be to improve cardiac MRI workflows and diagnostic tools to expand accessibility and use of the modality to electrophysiology procedures such as atrial fibrillation and ventricular tachycardia ablations.

The announcement was made at the Society for Cardiovascular Magnetic Resonance (SCMR) 2019 meeting, Feb. 6-9 in Bellevue, Wash.

Circle’s imaging platform, cvi42 is a cardiovascular imaging reading and reporting solution for cardiac MR, cardiac computed tomography (CT) and cardiac interventional planning. cvi42 provides physicians the tools to accurately quantify and diagnose complex cardiovascular diseases while improving patient outcomes and the effective utilization of healthcare resources. Currently at version 5.10, cvi42 utilizes machine learning and big data, with the machine results demonstrating capabilities within the same range as expert human readers.

Galgo Medical SL is a Barcelona-based company that emerged from the Department of Information Technologies (DTIC) at the Universitat Pompeu Fabra (Barcelona, Spain). Its ADAS 3D family of products is intended for the identification of arrhythmia substrate and the planning of ablation procedures using cardiac MRI and CT.                     

For more information: www.circlecvi.com, www.adas3d.com


Related Content

News | ACC

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...

Home April 11, 2024
Home
News | ACC

April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST ...

Home April 06, 2024
Home
Feature | ACC | Christine Book

April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization ...

Home April 03, 2024
Home
News | ACC

March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II ...

Home March 26, 2024
Home
Feature | ACC | By Melinda Taschetta-Millane

The American College of Cardiology (ACC) has announced key educational and programming highlights for its ACC 73rd ...

Home March 25, 2024
Home
News | ACC

March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal ...

Home March 21, 2024
Home
News | ACC

March 7, 2024 — The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd ...

Home March 07, 2024
Home
News | ACC

February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific Session ...

Home February 29, 2024
Home
News | ACC

February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac ...

Home February 14, 2024
Home
News | ACC

February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing ...

Home February 07, 2024
Home
Subscribe Now